rb 6145 has been researched along with rb 7040 in 1 studies
| Studies (rb 6145) | Trials (rb 6145) | Recent Studies (post-2010) (rb 6145) | Studies (rb 7040) | Trials (rb 7040) | Recent Studies (post-2010) (rb 7040) |
|---|---|---|---|---|---|
| 38 | 0 | 2 | 6 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, GE; Cole, S; Fielden, EM; Jenkins, TC; Naylor, MA; O'Neill, P; Stier, MA; Stratford, IJ; Suto, MJ; Threadgill, MD | 1 |
1 other study(ies) available for rb 6145 and rb 7040
| Article | Year |
|---|---|
Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activate
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cytotoxins; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Prodrugs; Radiation-Sensitizing Agents | 1990 |